메뉴 건너뛰기




Volumn 34, Issue 5, 2016, Pages 419-426

Erratum: Correlative analysis of genetic alterations and everolimus benefit in hormone receptor–Positive, human epidermal growth factor receptor 2–Negative advanced breast cancer: Results from BOLERO-2 (Journal of Clinical Oncology (2016) 34 (419-426) DOI: 10.1200/JCO.2014.60.1971);Correlative analysis of genetic alterations and everolimus benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Results from BOLERO-2

(25)  Hortobagyi, Gabriel N a   Chen, David b   Piccart, Martine c   Rugo, Hope S e   Burris, Howard A g   Pritchard, Kathleen I h   Campone, Mario i   Noguchi, Shinzaburo k   Perez, Alejandra T m   Deleu, Ines d   Shtivelband, Mikhail n   Masuda, Norikazu l   Dakhil, Shaker o   Anderson, Ian f   Robinson, Douglas M p   He, Wei p   Garg, Abhishek p   McDonald, E Robert p   Bitter, Hans p   Huang, Alan p   more..


Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EVEROLIMUS; EXEMESTANE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; PLACEBO; AROMATASE INHIBITOR; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

EID: 84958973417     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.18.02212     Document Type: Erratum
Times cited : (206)

References (38)
  • 1
    • 84863078767 scopus 로고    scopus 로고
    • Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer
    • Baselga J, Campone M, Piccart M, et al: Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.NEngl JMed 366:520-529, 2012
    • (2012) NEngl JMed , vol.366 , pp. 520-529
    • Baselga, J.1    Campone, M.2    Piccart, M.3
  • 2
    • 35948964043 scopus 로고    scopus 로고
    • Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas
    • Barbareschi M, Buttitta F, Felicioni L, et al: Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. Clin Cancer Res 13:6064-6069, 2007
    • (2007) Clin Cancer Res , vol.13 , pp. 6064-6069
    • Barbareschi, M.1    Buttitta, F.2    Felicioni, L.3
  • 3
    • 84877028141 scopus 로고    scopus 로고
    • Comprehensive molecular portraits of human breast tumours
    • Cancer Genome Atlas Network: Comprehensive molecular portraits of human breast tumours. Nature 490:61-70, 2012
    • (2012) Nature , vol.490 , pp. 61-70
    • Cancer Genome Atlas Network1
  • 4
    • 84864395175 scopus 로고    scopus 로고
    • The favorable impact of PIK3CA mutations on survival: An analysis of 2587 patients with breast cancer
    • Dumont AG, Dumont SN, Trent JC: The favorable impact of PIK3CA mutations on survival: An analysis of 2587 patients with breast cancer. Chin J Cancer 31:327-334, 2012
    • (2012) Chin J Cancer , vol.31 , pp. 327-334
    • Dumont, A.G.1    Dumont, S.N.2    Trent, J.C.3
  • 5
    • 84862584058 scopus 로고    scopus 로고
    • Whole-genome analysis informs breast cancer response to aromatase inhibition
    • Ellis MJ, Ding L, Shen D, et al: Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 486:353-360, 2012
    • (2012) Nature , vol.486 , pp. 353-360
    • Ellis, M.J.1    Ding, L.2    Shen, D.3
  • 6
    • 83455162719 scopus 로고    scopus 로고
    • Variants on the promoter region of PTEN affect breast cancer progression and patient survival
    • Heikkinen T, Greco D, Pelttari LM, et al: Variants on the promoter region of PTEN affect breast cancer progression and patient survival. Breast Cancer Res 13:R130, 2011
    • (2011) Breast Cancer Res , vol.13 , pp. R130
    • Heikkinen, T.1    Greco, D.2    Pelttari, L.M.3
  • 7
    • 84877796247 scopus 로고    scopus 로고
    • Comprehensive analysis of PTEN status in breast carcinomas
    • Jones N, Bonnet F, Sfar S, et al: Comprehensive analysis of PTEN status in breast carcinomas. Int J Cancer 133:323-334, 2013
    • (2013) Int J Cancer , vol.133 , pp. 323-334
    • Jones, N.1    Bonnet, F.2    Sfar, S.3
  • 8
    • 77953422867 scopus 로고    scopus 로고
    • PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer
    • Loi S, Haibe-Kains B, Majjaj S, et al: PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer. Proc Natl Acad Sci U S A 107:10208-10213, 2010
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 10208-10213
    • Loi, S.1    Haibe-Kains, B.2    Majjaj, S.3
  • 9
    • 84861576201 scopus 로고    scopus 로고
    • The landscape of cancer genes and mutational processes in breast cancer
    • Stephens PJ, Tarpey PS, Davies H, et al: The landscape of cancer genes and mutational processes in breast cancer. Nature 486:400-404, 2012
    • (2012) Nature , vol.486 , pp. 400-404
    • Stephens, P.J.1    Tarpey, P.S.2    Davies, H.3
  • 10
    • 84887491073 scopus 로고    scopus 로고
    • Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
    • Frampton GM, Fichtenholtz A, Otto GA, et al: Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol 31:1023-1031, 2013
    • (2013) Nat Biotechnol , vol.31 , pp. 1023-1031
    • Frampton, G.M.1    Fichtenholtz, A.2    Otto, G.A.3
  • 11
    • 84888391516 scopus 로고    scopus 로고
    • ESR1 ligandbinding domain mutations in hormone-resistant breast cancer
    • Toy W, Shen Y, Won H, et al: ESR1 ligandbinding domain mutations in hormone-resistant breast cancer. Nat Genet 45:1439-1445, 2013
    • (2013) Nat Genet , vol.45 , pp. 1439-1445
    • Toy, W.1    Shen, Y.2    Won, H.3
  • 12
    • 84867333656 scopus 로고    scopus 로고
    • Genome sequencing identifies a basis for everolimus sensitivity
    • Iyer G, Hanrahan AJ, Milowsky MI, et al: Genome sequencing identifies a basis for everolimus sensitivity. Science 338:221, 2012
    • (2012) Science , vol.338 , pp. 221
    • Iyer, G.1    Hanrahan, A.J.2    Milowsky, M.I.3
  • 13
    • 84898732516 scopus 로고    scopus 로고
    • Tumor genetic analyses of patientswith metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    • Voss MH, Hakimi AA, Pham CG, et al: Tumor genetic analyses of patientswith metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy. Clin Cancer Res 20:1955-1964, 2014
    • (2014) Clin Cancer Res , vol.20 , pp. 1955-1964
    • Voss, M.H.1    Hakimi, A.A.2    Pham, C.G.3
  • 14
    • 84906805668 scopus 로고    scopus 로고
    • Luminal B breast cancer: Molecular characterization, clinical management, and future perspectives
    • Ades F, Zardavas D, Bozovic-Spasojevic I, et al: Luminal B breast cancer: Molecular characterization, clinical management, and future perspectives. J Clin Oncol 32:2794-2803, 2014
    • (2014) J Clin Oncol , vol.32 , pp. 2794-2803
    • Ades, F.1    Zardavas, D.2    Bozovic-Spasojevic, I.3
  • 15
    • 33748286796 scopus 로고    scopus 로고
    • A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
    • Carter SL, Eklund AC, Kohane IS, et al: A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38:1043-1048, 2006
    • (2006) Nat Genet , vol.38 , pp. 1043-1048
    • Carter, S.L.1    Eklund, A.C.2    Kohane, I.S.3
  • 16
    • 0037837441 scopus 로고    scopus 로고
    • Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatinbased chemotherapy in gastric carcinoma
    • Ott K, Vogelsang H, Mueller J, et al: Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatinbased chemotherapy in gastric carcinoma. Clin Cancer Res 9:2307-2315, 2003
    • (2003) Clin Cancer Res , vol.9 , pp. 2307-2315
    • Ott, K.1    Vogelsang, H.2    Mueller, J.3
  • 17
    • 84874458031 scopus 로고    scopus 로고
    • The CIN4 chromosomal instability qPCR classifier defines tumor aneuploidy and stratifies outcome in grade 2 breast cancer
    • Szasz AM, Li Q, Eklund AC, et al: The CIN4 chromosomal instability qPCR classifier defines tumor aneuploidy and stratifies outcome in grade 2 breast cancer. PLoS One 8:e56707, 2013
    • (2013) PLoS One , vol.8
    • Szasz, A.M.1    Li, Q.2    Eklund, A.C.3
  • 18
    • 84858842073 scopus 로고    scopus 로고
    • Tumor genetic testing for patient selection in phase i clinical trials: The case of PI3K inhibitors
    • Juric D, Baselga J: Tumor genetic testing for patient selection in phase I clinical trials: The case of PI3K inhibitors. J Clin Oncol 30:765-766, 2012
    • (2012) J Clin Oncol , vol.30 , pp. 765-766
    • Juric, D.1    Baselga, J.2
  • 19
    • 66849136781 scopus 로고    scopus 로고
    • Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer
    • Baselga J, Semiglazov V, van Dam P, et al: Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. J Clin Oncol 27:2630-2637, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 2630-2637
    • Baselga, J.1    Semiglazov, V.2    Van Dam, P.3
  • 20
    • 84859169877 scopus 로고    scopus 로고
    • The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
    • Barretina J, Caponigro G, Stransky N, et al: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483: 603-607, 2012
    • (2012) Nature , vol.483 , pp. 603-607
    • Barretina, J.1    Caponigro, G.2    Stransky, N.3
  • 21
    • 84866544615 scopus 로고    scopus 로고
    • Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110alpha (PIK3CA)
    • Burke JE, Perisic O, Masson GR, et al: Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110alpha (PIK3CA). Proc Natl Acad Sci U S A 109:15259-15264, 2012
    • (2012) Proc Natl Acad Sci U S A , vol.109 , pp. 15259-15264
    • Burke, J.E.1    Perisic, O.2    Masson, G.R.3
  • 22
    • 84864509652 scopus 로고    scopus 로고
    • FGFR1 is amplified during the progression of in situ to invasive breast carcinoma
    • Jang MH, Kim EJ, Choi Y, et al: FGFR1 is amplified during the progression of in situ to invasive breast carcinoma. Breast Cancer Res 14:R115, 2012
    • (2012) Breast Cancer Res , vol.14 , pp. R115
    • Jang, M.H.1    Kim, E.J.2    Choi, Y.3
  • 23
    • 77950278598 scopus 로고    scopus 로고
    • FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer
    • Turner N, Pearson A, Sharpe R, et al: FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. Cancer Res 70:2085-2094, 2010
    • (2010) Cancer Res , vol.70 , pp. 2085-2094
    • Turner, N.1    Pearson, A.2    Sharpe, R.3
  • 24
    • 80051558985 scopus 로고    scopus 로고
    • High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1
    • Karlsson E, Waltersson MA, Bostner J, et al: High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1. Genes Chromosomes Cancer 50:775-787, 2011
    • (2011) Genes Chromosomes Cancer , vol.50 , pp. 775-787
    • Karlsson, E.1    Waltersson, M.A.2    Bostner, J.3
  • 25
    • 67349202517 scopus 로고    scopus 로고
    • Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis
    • Kwek SS, Roy R, Zhou H, et al: Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis. Oncogene 28:1892-1903, 2009
    • (2009) Oncogene , vol.28 , pp. 1892-1903
    • Kwek, S.S.1    Roy, R.2    Zhou, H.3
  • 26
    • 33947422035 scopus 로고    scopus 로고
    • Coamplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event
    • Paterson AL, Pole JC, Blood KA, et al: Coamplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event. Genes Chromosomes Cancer 46:427-439, 2007
    • (2007) Genes Chromosomes Cancer , vol.46 , pp. 427-439
    • Paterson, A.L.1    Pole, J.C.2    Blood, K.A.3
  • 27
    • 84879859652 scopus 로고    scopus 로고
    • Targeting FGFR with dovitinib (TKI258): Preclinical and clinical data in breast cancer
    • Andre F, Bachelot T, Campone M, et al: Targeting FGFR with dovitinib (TKI258): Preclinical and clinical data in breast cancer. Clin Cancer Res 19: 3693-3702, 2013
    • (2013) Clin Cancer Res , vol.19 , pp. 3693-3702
    • Andre, F.1    Bachelot, T.2    Campone, M.3
  • 28
    • 84874088896 scopus 로고    scopus 로고
    • Significant antitumor activity of E-3810, a novel FGFR and VEGFR inhibitor, in patients with FGFR1 amplified breast cancer
    • (abstr 319O)
    • Dienstmann R, Andre F, Soria J, et al: Significant antitumor activity of E-3810, a novel FGFR and VEGFR inhibitor, in patients with FGFR1 amplified breast cancer. Ann Oncol 23:ix116-ix117, 2012 (abstr 319O)
    • (2012) Ann Oncol , vol.23 , pp. ix116-ix117
    • Dienstmann, R.1    Andre, F.2    Soria, J.3
  • 29
    • 78049261497 scopus 로고    scopus 로고
    • Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer
    • Burrell RA, Juul N, Johnston SR, et al: Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer. J Cell Biochem 111:782-790, 2010
    • (2010) J Cell Biochem , vol.111 , pp. 782-790
    • Burrell, R.A.1    Juul, N.2    Johnston, S.R.3
  • 30
    • 84878546031 scopus 로고    scopus 로고
    • Taxane benefit in breast cancer - A role for grade and chromosomal stability
    • A'Hern RP, Jamal-Hanjani M, Szasz AM, et al: Taxane benefit in breast cancer-a role for grade and chromosomal stability. Nat Rev Clin Oncol 10: 357-364, 2013
    • (2013) Nat Rev Clin Oncol , vol.10 , pp. 357-364
    • A'Hern, R.P.1    Jamal-Hanjani, M.2    Szasz, A.M.3
  • 31
    • 39749108733 scopus 로고    scopus 로고
    • High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
    • Chin SF, Teschendorff AE, Marioni JC, et al: High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 8:R215, 2007
    • (2007) Genome Biol , vol.8 , pp. R215
    • Chin, S.F.1    Teschendorff, A.E.2    Marioni, J.C.3
  • 32
    • 84879266916 scopus 로고    scopus 로고
    • A novel measure of chromosome instability can account for prognostic difference in multiple myeloma
    • Chung TH, Mulligan G, Fonseca R, et al: A novel measure of chromosome instability can account for prognostic difference in multiple myeloma. PLoS One 8:e66361, 2013
    • (2013) PLoS One , vol.8
    • Chung, T.H.1    Mulligan, G.2    Fonseca, R.3
  • 33
    • 84856513068 scopus 로고    scopus 로고
    • Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors
    • Lagarde P, Perot G, Kauffmann A, et al: Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors. Clin Cancer Res 18: 826-838, 2012
    • (2012) Clin Cancer Res , vol.18 , pp. 826-838
    • Lagarde, P.1    Perot, G.2    Kauffmann, A.3
  • 34
    • 77954535843 scopus 로고    scopus 로고
    • Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity
    • Chibon F, Lagarde P, Salas S, et al: Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 16:781-787, 2010
    • (2010) Nat Med , vol.16 , pp. 781-787
    • Chibon, F.1    Lagarde, P.2    Salas, S.3
  • 35
    • 84875466344 scopus 로고    scopus 로고
    • Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas
    • Lagarde P, Przybyl J, Brulard C, et al: Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas. J Clin Oncol 31:608-615, 2013
    • (2013) J Clin Oncol , vol.31 , pp. 608-615
    • Lagarde, P.1    Przybyl, J.2    Brulard, C.3
  • 36
    • 0031669861 scopus 로고    scopus 로고
    • P53 mutations and DNA ploidy in colorectal adenocarcinomas
    • Campomenosi P, Assereto P, Bogliolo M, et al: p53 mutations and DNA ploidy in colorectal adenocarcinomas. Anal Cell Pathol 17:1-12, 1998
    • (1998) Anal Cell Pathol , vol.17 , pp. 1-12
    • Campomenosi, P.1    Assereto, P.2    Bogliolo, M.3
  • 37
    • 77950521355 scopus 로고    scopus 로고
    • P53 suppresses structural chromosome instability after mitotic arrest in human cells
    • Dalton WB, Yu B, Yang VW: p53 suppresses structural chromosome instability after mitotic arrest in human cells. Oncogene 29:1929-1940, 2010
    • (2010) Oncogene , vol.29 , pp. 1929-1940
    • Dalton, W.B.1    Yu, B.2    Yang, V.W.3
  • 38
    • 0034691217 scopus 로고    scopus 로고
    • Chromosome instability contributes to loss of heterozygosity inmice lacking p53
    • Shao C, Deng L, Henegariu O, et al: Chromosome instability contributes to loss of heterozygosity inmice lacking p53. Proc Natl Acad Sci U S A 97:7405-7410, 2000
    • (2000) Proc Natl Acad Sci U S A , vol.97 , pp. 7405-7410
    • Shao, C.1    Deng, L.2    Henegariu, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.